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Introduction
Insulin resistance, a condition in which the cells become res-
istant to the effects of insulin, is a major risk factor for type 2 
diabetes as well as hypertension, dyslipidemia, and atheroscle-
rosis (Reaven, 1988). Despite several investigations, the molecular 
mechanism underlying insulin resistance has not been ade-
quately clarifi  ed. TNF-α is an adipocytokine and induces  insulin 
resistance (Hotamisligil et al., 1993). A TNF-α signal   results in 
the phosphorylation of Ser
307 of insulin receptor (IR) substrate 1 
(IRS-1), in turn attenuating the metabolic insulin signal (Kanety 
et al., 1995). Many serine kinases such as JNK, glycogen syn-
thase kinase 3, and mammalian target of rapamycin have been 
reported to phosphorylate serine residues of IRS-1 (Gao et al., 
2002). However, the serine kinase that precisely regulates meta-
bolic insulin action is unclear.
After the fi  rst report of type 2 diabetes being successfully 
treated with high-dose salicylate in 1901 (Williamson and Lond, 
1901), numerous attempts have been made to identify the target 
molecules of salicylate. In 1998, salicylate was reported to be 
a strong inhibitor of the kinase activity of IκB kinase (IKK) β 
(Yin et al., 1998). Since then, studies have focused on the IKK 
complex as a critical molecule for the development of insulin 
  resistance (Yuan et al., 2001). The IKK complex consists of two 
catalytic subunits, IKK-α and IKK-β, and one scaffold subunit 
designated nuclear factor κB essential modulator (NEMO)/IKK-γ 
(DiDonato et al., 1997; Nakano et al., 1998; Yamaoka et al., 
1998). Among these subunits, IKK-β is a key insulin resistance 
molecule, as demonstrated by a study using the IKK-β knockout 
mouse (Kim et al., 2001). A recent study showed the IKK com-
plex to phosphorylate IRS-1 at Ser
307, which is associated with 
TNF-α stimulation and diminished insulin signaling (Gao et al., 
2002). However, whether IKK-β itself physically binds to IRS-1 
is uncertain. Furthermore, the role of NEMO is also unclear.
Myo1c is a motor protein that is classifi  ed as an uncon-
ventional myosin I. This class of myosins is widely distributed, 
having been identifi  ed in organisms from yeast to human. 
In  adipocytes, Myo1c reportedly facilitates the recycling of vesicles 
containing glucose transporter 4 (Bose et al., 2002). However, 
little is known about the molecular mechanisms regulating 
motor Myo1c–cargo interactions.
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T
umor necrosis factor-α (TNF-α) signaling through 
the IκB kinase (IKK) complex attenuates insulin 
action via the phosphorylation of insulin receptor 
substrate 1 (IRS-1) at Ser
307. However, the precise molecu-
lar mechanism by which the IKK complex phosphorylates 
IRS-1 is unknown. In this study, we report nuclear factor 
κB essential modulator (NEMO)/IKK-γ subunit accumula-
tion in membrane rufﬂ  es followed by an interaction with 
IRS-1. This intracellular trafﬁ   cking of NEMO requires 
  insulin, an intact actin cytoskeletal network, and the motor 
protein  Myo1c. Increased Myo1c expression enhanced 
the NEMO–IRS-1 interaction, which is essential for TNF-α–
  induced phosphorylation of Ser
307–IRS-1. In contrast, 
dominant inhibitory Myo1c cargo domain expression 
  diminished this interaction and inhibited IRS-1 phosphor-
ylation. NEMO expression also enhanced TNF-α–induced 
Ser
307–IRS-1 phosphorylation and inhibited glucose uptake. 
In contrast, a deletion mutant of NEMO lacking the IKK-β–
binding domain or silencing NEMO blocked the TNF-α 
  signal. Thus, motor protein Myo1c and its receptor protein 
NEMO act cooperatively to form the IKK–IRS-1 complex 
and function in TNF-α–induced insulin resistance.
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We investigated the formation of the functional complex 
of   signaling molecules containing IKKs and IRS-1 in response 
to insulin. We found that NEMO functions as a motor receptor, 
whereas Myo1c and the actin cytoskeleton facilitate transloca-
tion of the IKK complex to membrane ruffl  es or to the vicinity 
of IRS-1. This interaction between IKKs and IRS-1 is essential 
for TNF-α–induced phosphorylation of IRS-1 at Ser
307, which 
results in the inhibition of glucose uptake. Our present results 
suggest a novel mechanism whereby Myo1c–NEMO-mediated 
signaling complex formation plays a role in TNF-α–induced 
 insulin  resistance.
Results and discussion
NEMO translocates to membrane rufﬂ  es 
in response to insulin
Researchers have reported that IKK-β is crucial for TNF-α–
  induced IRS-1 serine phosphorylation (Gao et al., 2002; de 
  Alvaro et al., 2004). However, the role of the NEMO/IKK-γ 
subunit is poorly understood. We fi  rst examined the intracellular 
localization of NEMO in differentiated 3T3-L1 adipocytes using 
anti-NEMO antibody. As shown in Fig. 1 A, NEMO results in 
a fi  ne punctate or granular appearance throughout the cytoplasm 
under basal and TNF-α–treated conditions. In contrast, the 
  addition of insulin to culture adipocytes yields the rapid translo-
cation of NEMO to the cell periphery, especially in membrane 
ruffl  es visualized by staining with AlexaFluor596-phalloidin. 
This translocation is similar to that seen in other cell types (Weil 
et al., 2003). Interestingly, treatment with the actin depolymer-
izer latrunculin B inhibited NEMO translocation, whereas the 
microtubule disrupter nocodazole did not (Fig. 1 B). These data 
suggest that insulin stimulates the accumulation of NEMO at 
membrane ruffl  es through the cortical actin network.
Identiﬁ  cation of motor protein Myo1c 
as a NEMO-binding partner
Because NEMO has neither an actin-binding motif nor a 
  membrane-targeting domain, we attempted to identify NEMO-
binding proteins using mass spectrometry. 3T3-L1 adipocytes 
were infected with an adenovirus vector containing myc-tagged 
full-length NEMO and were treated with 20 ng/ml TNF-α 
or 100 nM insulin for 20 min. The cell lysates were immuno-
precipitated with anti-myc antibody. The precipitates were 
Figure 1.  Intracellular localization of NEMO in 3T3-L1 adipocytes. 
Differentiated 3T3-L1 adipocytes (A) or adipocytes expressing eGFP-NEMO 
(B) were serum starved and either left untreated (A) or were   pretreated with 
5 μM latrunculin B (LatB) or 30 μM nocodazole (Noc) for 60 min (B). 
They were then incubated with 20 ng/ml TNF-α or 100 nM insulin for 
15 min at 37°C. The cells were ﬁ   xed, and F-actin was visualized by 
AlexaFluor596-phalloidin.
Figure 2.  Insulin promotes the interaction between NEMO and Myo1c. 
(A) 3T3-L1 adipocytes expressing myc-tagged WT NEMO were serum 
starved and stimulated with 100 nM insulin or 20 ng/ml TNF-α for 20 min 
at 37°C. NEMO-binding proteins were immunoprecipitated with anti-myc 
antibody, separated by SDS-PAGE, and visualized by silver staining. Bands 
were proteolytically digested and analyzed by mass spectrometry. Myo1c 
and actin (arrows) were identiﬁ   ed. (B) 3T3-L1 adipocytes were serum 
starved for 2 h and treated with 100 nM insulin or 20 ng/ml TNF-α for 
20 min at 37°C. The NEMO–Myo1c interaction was determined by immuno-
precipitation using anti-NEMO or anti-Myo1c antibodies.MYO1C AND NEMO IN TNF-α–INDUCED INSULIN RESISTANCE • NAKAMORI ET AL. 667
  resolved by SDS-PAGE and visualized with silver staining. 
With in-gel digestion followed by peptide mass fi  ngerprinting, 
we identifi  ed two candidate proteins, Myo1c and actin, showing 
  increased binding to NEMO in the presence of insulin (Fig. 2 A,
arrowheads). A series of experiments were performed to 
 confi  rm the interaction between NEMO and Myo1c. We fi  rst 
examined endogenous protein–protein interactions by immuno-
precipitation using polyclonal anti-NEMO– and polyclonal 
anti-Myo1c– specifi  c antibodies. As shown in Fig. 2 B, insulin 
treatment increased NEMO–Myo1c binding. We next confi  rmed 
this interaction using recombinant proteins in vitro. GST-tagged 
NEMO and His-tagged Myo1c were purifi  ed, mixed, and pulled
down with each other. As shown in Fig. S1 (available at 
http://www.jcb.org/cgi/content/full/jcb.200601065/DC1), the
interaction was easily detected by immunoblotting. These results 
suggest that NEMO and Myo1c interact directly in an insulin-
dependent manner.
Myo1c conveys NEMO
Based on the results presented in Figs. 1 and 2, we hypothesized 
that the IKK complex containing NEMO is transported from the 
cytosol to membrane ruffl  es by Myo1c. To examine this possi-
bility, we conducted experiments using the dominant inhibitory 
cargo domain of Myo1c. Overexpression of this cargo domain 
(residues 767–1,028) has been shown to result in the dominant 
inhibition of cargo binding (Bose et al., 2002). 3xFlag-tagged 
full-length Myo1c (wild type [WT]) or the dominant inhibitory 
cargo domain of Myo1c was cotransfected into culture adipo-
cytes with enhanced GFP (eGFP)–tagged NEMO. In cells co-
expressing Myo1c WT and eGFP-NEMO, NEMO showed marked 
translocation to membrane ruffl  es with insulin stimulation. 
  Interestingly, Myo1c WT also accumulated in the membrane 
and enhanced Myo1c expression, resulting in the extensive 
  formation of membrane ruffl  es (Fig. 3 A). In contrast, cells 
 expressing Myo1c cargo domain and NEMO showed the marked 
inhibition of insulin-stimulated NEMO translocation. Similar 
inhibition of NEMO translocation was observed in Myo1c 
knockdown cells using adenovirus encoding short hairpin RNA 
(shRNA [Myo1c]; Fig. 3 B).
We observed the association between NEMO and Myo1c 
biochemically (Fig. 2). We also found that membrane targeting 
of NEMO requires a motor protein, Myo1c (Fig. 3). Collectively, 
the data indicate the scaffold protein NEMO to be transported 
to membrane ruffl  es by the motor protein Myo1c. These observa-
tions are consistent with our aforementioned hypothesis.
Myo1c promotes IRS-1–IKK interaction and 
mediates Ser
307 phosphorylation on IRS-1
A recent study showed that IKKs interact with IRS-1 and inter-
fere with insulin signaling (Gao et al., 2002). To confi  rm this 
interaction in culture adipocytes, we fi  rst examined the localiza-
tion of endogenous NEMO and IRS-1 (Fig. 4 A) or Xpress-
tagged NEMO and eGFP-tagged IRS-1 (Fig. 4, B and C). In the 
basal state, IRS-1 was present in the cytoplasm, whereas with 
insulin stimulation, IRS-1 and NEMO colocalized to discrete 
foci in the cytoplasm as well as membrane ruffl  es. These obser-
vations on the intracellular localization of IRS-1 were very sim-
ilar to those described in a study by Luo et al. (2005). They 
reported a mechanism of IRS-1 signal down-regulation involving 
the formation of a sequestration complex containing IRS-1 in 
Figure 3.  Effect of Myo1c expression on the intracellular localization of NEMO. 3T3-L1 adipocytes were coexpressed with eGFP-NEMO and WT Myo1c 
or the Myo1c cargo domain (A) or were infected with adenovirus encoding shRNA (Myo1c) or vector alone. After 2 h of serum starvation, the cells were 
stimulated with or without 100 nM insulin for 20 min at 37°C, stained with anti-Flag antibody followed by Cy3-labeled secondary antibody (A) or anti-
NEMO antibody and anti-Myo1c antibody followed by FITC and Cy3-labeled secondary antibodies (B), and were observed by confocal microscopy.JCB • VOLUME 173 • NUMBER 5 • 2006  668
CHO-K1 cells. Interestingly, the large intracellular IRS-1 com-
plexes (foci) appeared to be the negative regulatory machinery.
We next examined the direct interaction between endog-
enous IRS-1 and NEMO by immunoprecipitation (Fig. 4 D). 
  Interestingly, the overexpression of Myo1c markedly increased 
this interaction. In contrast, cells overexpressing the domi-
nant inhibitory cargo domain of Myo1c showed a diminished 
  interaction. One interpretation of these fi  ndings is that Myo1c 
mediates the interaction by delivering NEMO to IRS-1. This 
explanation is supported by another set of experiments shown 
in Fig. S2 (A and B; available at http://www.jcb.org/cgi/
content/full/jcb.200601065/DC1). These experiments focused 
on Myo1c–IKK-β and IRS-1–IKK-β associations. When NEMO
was knocked down, the Myo1c–IKK-β interaction was  disturbed. 
Similarly, the overexpression of ∆N-NEMO   (detailed in the 
next section) diminished the IRS-1–IKK-β interaction. These 
results, combined with the data shown in Fig. 3, are   consistent 
with our hypothesis that Myo1c transports the IKK complex via 
binding to NEMO.
Another interesting observation illustrated in Fig. 4 D was 
that insulin enhanced the association between IRS-1 and IKK-β. 
These data raise the possibility that insulin may assemble clus-
ters of signaling molecules to facilitate the interaction   between 
IKKs and IRS-1. To assess this possible new role of insulin, 
we performed two additional experiments. First, we observed 
IRS-1 Ser
307 phosphorylation induced by TNF-α after treatment 
with various concentrations of insulin (Fig. 4 E). Although 
TNF-α–induced serine phosphorylation of IRS-1 was detected 
within 20 min even in the absence of insulin, a low concentra-
tion of insulin markedly enhanced TNF-α–induced Ser
307 phos-
phorylation. These data are consistent with the results presented 
in Fig. 4 D. Next, we also observed Ser
307 phosphorylation of 
IRS-1 in adipocytes expressing WT Myo1c and dominant 
 inhibitory Myo1c. Overexpression of dominant inhibitory Myo1c 
diminished Ser
307 phosphorylation of IRS-1 (Fig. S3 A, available 
at http://www.jcb.org/cgi/content/full/jcb.200601065/DC1). 
These results show that Myo1c promotes the interaction  between 
IRS-1 and NEMO and mediates Ser
307 phosphorylation of IRS-1. 
Furthermore, a low dose of insulin and an intact actin cytoskel-
eton may be necessary for clustering molecules related to TNF-α 
to down-regulate IRS-1.
Effects of NEMO and Myo1c expression 
on insulin signaling and glucose transport
Because IRS-1 protein is a key mediator of insulin signaling, 
we next focused on the roles of Myo1c and NEMO in insulin 
signaling and glucose transport. We prepared WT NEMO and 
NH2-terminal–deleted (∆N; residues 101–412) NEMO constructs 
Figure 4.  Myo1c modulates IRS-1–NEMO interaction. (A) 3T3-L1 adipocytes were serum starved for 2 h and stimulated with or without 100 nM insulin for 
15 min at 37°C. Cells were ﬁ  xed and stained with anti–IRS-1 and anti-NEMO antibody followed by FITC and Cy3-labeled secondary antibodies. (B) eGFP-
tagged IRS-1 and Xpress-fused NEMO were coexpressed in 3T3-L1 adipocytes. After 2 h of serum starvation, the cells were stimulated with or without 
100 nM insulin for 15 min and were then ﬁ  xed. Expressed NEMO was visualized by anti-Xpress antibody and a Cy3-labeled second antibody. (C) High 
resolution view of the boxed area outlined in B. (D) 3T3-L1 adipocytes were infected with adenovirus encoding WT Myo1c and dominant inhibitory Myo1c. 
The cells were stimulated with or without 100 nM insulin for 15 min. The cell lysates were immunoprecipitated with anti-NEMO antibody, and precipitates 
were immunoblotted with anti–IRS-1 antibody. (E) 3T3-L1 adipocytes were left untreated or treated with 20 ng/ml TNF-α for 10 min and were incubated 
with various concentrations (1–100 nM) of insulin for 10 min at 37°C. The cells were lysed and immunoprecipitated by anti–IRS-1 antibody, and the precip-
itates were blotted with antiphospho-Ser
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and performed a series of experiments. The NH2 terminal of 
NEMO is the IKK-β–binding site, and deletion of this site was 
shown to impair the binding of NEMO with IKK-β (Yamamoto 
et al., 2001).
First, we assessed the effects of NEMO expression on 
  upstream insulin signal cascades in 3T3-L1 adipocytes. Over-
expression of WT NEMO induced the phosphorylation of IRS-1 
Ser
307 while decreasing Akt phosphorylation in the absence 
of TNF-α. Overexpression of ∆N-NEMO prevented the phos-
phorylation of IRS-1 Ser
307 and inhibited Akt phosphorylation. 
We detected no changes in the tyrosine phosphorylation of the 
IR β chain (Fig. 5 A). Second, we measured 2-deoxyglucose 
uptake in 3T3-L1 adipocytes expressing NEMO constructs. 
Overexpression of WT NEMO abolished insulin-stimulated 
glucose uptake in the absence of TNF-α. In contrast, the over-
expression of ∆N-NEMO completely blocked the inhibitory 
 effects  of  TNF-α (Fig. 5 B). Third, we introduced shRNA into 
culture adipocytes to induce specifi  c degradation of NEMO 
mRNA. NEMO protein expression was decreased to 20–30% of 
the control level (unpublished data). As expected, the deletion 
of NEMO almost completely blocked the inhibition of insulin-
stimulated glucose uptake by TNF-α (Fig. 5 D). Under these 
conditions, IR-β tyrosine, IRS-1 Ser
307, and Akt Ser
473 phosphory-
lations were examined in 3T3-L1 adipocytes. NEMO silencing 
by shRNA also prevented TNF-α–mediated IRS-1 Ser
307 phos-
phorylation and inhibition of Akt phosphorylation without 
  affecting IR tyrosine phosphorylation (Fig. 5 C). These data, 
combined with the data presented in Figs. 3 and 4, suggest that 
motor protein Myo1c and its receptor protein NEMO mediate 
TNF-α–induced down-regulation of IRS-1 and glucose uptake.
However, it was previously shown that the overexpres-
sion of ∆N-NEMO results in the loss of IKK kinase activity 
  (Yamamoto et al., 2001). We confi  rmed the inhibition of IKK 
kinase activity in 3T3-L1 adipocytes expressing ∆N-NEMO as 
well as NEMO knockdown cells (Fig. S3, B and C). These ob-
servations indicated that NEMO plays a role in assembling the 
IKK complex and that this step is critical for IKK kinase activity. 
To avoid this bias and clarify the roles of Myo1c and NEMO in 
glucose uptake, we conducted another experiment using Myo1c 
cargo domain constructs. As shown in Fig. 5 E, overexpression 
of the cargo domain inhibited the TNF-α–induced suppression 
of glucose uptake. Together, these results provide evidence that 
NEMO may function as a receptor molecule for Myo1c and that 
Myo1c promotes the TNF-α–induced suppression of metabolic 
insulin action. In agreement with a previous study (Bose et al., 
2002), we confi  rmed that Myo1c cargo domain expression itself 
decreased insulin-stimulated glucose uptake by 30%. This may 
be a result of the inhibitory role of Myo1c on GLUT4 recycling 
(Bose et al., 2002).
Based on the aforementioned data, we propose a simple 
model whereby Myo1c and its receptor NEMO cooperatively 
 facilitate IKK–IRS-1 complex formation, as illustrated in Fig. 5 F. 
NEMO is a scaffold protein of the IKK complex. Recent studies 
suggest that some scaffold proteins serve as links between 
Figure 5.  NEMO and Myo1c for insulin signaling and glucose uptake in 3T3-L1 adipocytes. (A–E) 3T3-L1 adipocytes were infected with recombinant adeno-
virus encoding wild type (WT) NEMO, ∆N-NEMO, shRNA (NEMO), Myo1c WT, Myo1c cargo domain, and vector alone (for control) at an MOI of 50. 
(A and C) The cells were serum starved for 2 h, treated with or without 20 ng/ml TNF-α for 15 min, and stimulated with or without 100 nM insulin for 
10 min at 37°C. The cell lysates were immunoprecipitated with anti–insulin receptor β (IR-β) or anti–IRS-1 antibody, and the precipitates were immunoblotted 
with antiphosphotyrosine, anti–IR-β, anti–IRS-1, antiphospho-Ser
307 IRS-1, antiphospho-Ser
473 Akt, and anti-Akt antibodies. (B, D, and E) The cells were 
  serum starved for 2 h in Krebs-Ringer phosphate buffer and treated with 20 ng/ml TNF-α for 4 h. Glucose uptake was measured. Each bar represents the 
mean ± SD (error bars) value of at least three independent experiments. (F) Schematic model of Myo1c-mediated IRS-1–IKK complex formation.JCB • VOLUME 173 • NUMBER 5 • 2006  670
  molecular motors and intracellular vesicles, thereby functioning 
as cargo proteins (Dorner et al., 1999; Setou et al., 2000). 
In contrast, our data suggest that the scaffold protein NEMO 
links motor and signaling molecules as cargos. It is noteworthy 
that Myo1c organizes the signaling complex and serves as a 
platform for the two distinct signals to interact (i.e., the insulin 
signal and the TNF-α signal mediating insulin resistance).
Finally, our results allow us to draw three conclusions. 
First, the motor protein Myo1c appears to participate directly 
in the mechanism of IRS-1–IKK complex formation in culture 
adipocytes. It is possible that NEMO is a molecular receptor 
linking motor (Myo1c) and cargo (IKK-α and -β). Second, 
NEMO and Myo1c may be involved in the TNF-α–induced 
Ser
307 phosphorylation of IRS-1, resulting in the attenuation of 
insulin signaling and glucose transport. Third, Myo1c and the 
actin cytoskeleton may facilitate formation of the signaling 
molecule complex that participates in the TNF-α–induced 
down-regulation of IRS-1. In summary, our data suggest that 
Myo1c and NEMO are responsible for the mechanism of 
TNF-α–induced insulin resistance.
Materials and methods
Constructs
Mouse full-length NEMO and IRS-1 were cloned by RT-PCR ampliﬁ  cation 
with total mRNA from 3T3-L1 adipocytes. WT and an NH2-terminal deletion 
mutant of NEMO containing amino acid residues 101–412 were sub-
cloned into pEGFP-C2, pcDNA3.1His, pET-16b, and/or pGEX-6p-1   vectors. 
Mouse Myo1c cDNA was purchased from DNAFORM and subcloned into 
p3xFLAG-CMV7.1, pET-16b, and pGEX-6p-1 vectors. IKK-α and IKK-β 
cDNA were gifts from H. Nakano (Juntendo University School of Medicine, 
Tokyo, Japan).
Reagents and antibodies
The following antibodies were used: anti-NEMO, antiphospho-Ser
307 IRS-1, 
and antiphospho-Akt antibodies (Cell Signaling); anti-NEMO and anti–IRS-1 
antibodies (Upstate Biotechnology); anti-Flag antibody (Sigma-Aldrich); 
anti-Xpress antibody (Invitrogen); and Cy3-conjugated anti–mouse IgG 
(Jackson ImmunoResearch Laboratories). Rabbit polyclonal anti-Myo1c 
  antibody was generated against the peptide sequence D  K  S  E  L  S  D  K  K  R  P  E  . 
All other antibodies were purchased from Santa Cruz Biotechnology, Inc. 
AlexaFluor596-phalloidin was obtained from Invitrogen. Mouse TNF-α was 
purchased from PeproTech.
Cell culture
3T3-L1 ﬁ  broblasts were grown in DME with 10% FBS at 37°C. The cells 
(3–4-d after conﬂ  uence) differentiated into adipocytes with incubation in 
the same DME containing 0.5 mM isobutylmethylxanthine, 0.25 μM dexa-
methasone, and 4 μg/ml insulin for 3 d and were then grown in DME with 
10% FBS for an additional 3–6 d.
Immunoﬂ  uorescence microscopy and digital image analysis
Differentiated 3T3-L1 adipocytes were transfected by electroporation. The 
cells were then replated onto coverslips and allowed to recover for 48 h 
followed by stimulation with 100 nM insulin or 20 ng/ml TNF-α for 15 min 
at 37°C. Then, 5 μM latrunculin B or 30 μM nocodazole were added 
60 min before treatment with insulin. Minimum concentrations of these 
agents required for disrupting the cytoskeleton in culture adipocytes were 
determined previously (Emoto et al., 2001). Cells were ﬁ  xed with 3.7% 
formaldehyde in PBS, permeabilized with buffer A (0.5% Triton X-100 and 
1% FBS in PBS) for 15 min, and incubated for 2 h with primary antibodies 
at room temperature. The cells were washed and incubated with an appro-
priate secondary antibody or AlexaFluor596-phalloidin for 30 min. The 
coverslips were washed thoroughly and mounted on glass slides. Immuno-
stained cells were observed at room temperature with a laser-scanning 
confocal microscope (LSM5 PASCAL; Carl Zeiss MicroImaging, Inc.) and 
its two-channel scanning module equipped with an inverted microscope 
(Axiovert 200M; Carl Zeiss MicroImaging, Inc.). The inverted microscope 
used the 63× NA 1.4 oil objective lens run by LSM5 processing software 
(Carl Zeiss MicroImaging, Inc.) and Adobe Photoshop CS2.
Preparation of adenovirus
Adenovirus producing mouse WT NEMO, deletion mutant NEMO 
  (residues 101–412), mouse WT Myo1c, and dominant inhibitory Myo1c 
(residues 767–1,028) were prepared using an AdEasy Adenoviral   Vetor 
System (Stratagene).
shRNA-induced degradation of NEMO
shRNA was designed to have a 5′-A  A  G  G  A  T  T  C  G  A  G  C  A  G  T  T  A  G  T  G  A  G  C  -3′ 
sequence. Synthetic complementary single-stranded oligonucleotide DNA 
was annealed, and the double-stranded DNA of the target sequence was 
created. This annealed DNA was inserted into a pcPUR+U6i cassette 
  (Miyagishi and Taira, 2002), and the insert was transferred to an AdEasy 
Adenoviral Vector System. This shRNA system decreased NEMO protein 
expression to 20–30% of the control level.
Identiﬁ  cation of NEMO-binding proteins
Myc-NEMO was expressed in 3T3-L1 adipocytes. 2 d thereafter, cells were 
serum starved for 2 h and stimulated with 100 nM insulin or 20 ng/ml 
TNF-α for 20 min. Cell lysates were prepared and immunoprecipitated 
with anti-myc antibody. Samples were resolved by SDS-PAGE, and proteins 
were visualized by silver staining. The bands were excised and subjected 
to in-gel digestion according to the method described by Shevchenko et al. 
(1996) with minor modiﬁ  cations. Mass spectra were acquired using a time 
of ﬂ   ight mass spectrometer (Voyager DE Pro; Applied Biosystems). The 
search engine for the peptide mass ﬁ  ngerprint was the web-based Mascot 
(Matrix Science).
Details of in-gel digestion. In brief, the gel pieces were washed 
twice in 300 μl CH3CN for 30 min and dried. The gel pieces were then 
  rehydrated in 100 μl of reduction buffer (10 mM DTT and 100 mM 
NH4HCO3) and were left standing at 56°C for 1 h. After supernatant 
  removal, the gel pieces were incubated in 100 μl of 50 mM idotoacet-
amide in 100 mM NH4HCO3 for 45 min at room temperature. The gel 
pieces were then washed in 100 μl of 100 mM NH4HCO3 and dehy-
drated in 300 μl of acetonitrile. After washing and dehydration (twice 
each), the dried gel pieces were rehydrated on ice in 100 μl of digestion 
buffer (50 mM NH4HCO3 and 12.5 ng/μL each of lysylendopeptidase 
[Wako] and sequencing grade trypsin [Promega]) for 45 min. The super-
natant was   replaced with 50 mM NH4HCO3, and the gel pieces were 
  incubated at 37°C overnight. The supernatant was collected, and the 
  peptides were   extracted repeatedly with a 50-μl solution of 5% (vol/vol) 
formic acid and 50% (vol/vol) acetonitrile by vortexing. The combined su-
pernatants were evaporated to dryness in a vacuum centrifuge. Resulting 
peptides were   redissolved in 0.1% triﬂ  uoroacetic acid and absorbed onto 
ZipTip C18 (Millipore). Bound peptides were eluted with 50% acetonitrile 
and 0.1% triﬂ  uoroacetic acid. Equal amounts of the resulting peptide solu-
tion and a matrix-assisted laser desorption ionization sample matrix solution 
(10 mg/ml α-cyano-4-hydroxycinnamic acid dissolved in 50% acetonitrile 
and 0.1% triﬂ  uoroacetic acid) were mixed on the sample target.
Pull-down assay
GST-fused NEMO and Myo1c were expressed using a pGEX-6p-1 vector 
in BL21 cells. His-tagged NEMO and Myo1c were expressed using a 
pET-16b vector in BL21 (DE3) cells. GST-fused protein and His-tagged protein 
were mixed in PBS and pulled down with glutathione–Sepharose beads 
(GE Healthcare). Protein interactions were detected by Western blotting 
  using anti-His antibody and anti-GST antibody.
shRNA-induced degradation of Myo1c
Target sequences used in shRNA were the same as those described previ-
ously (Bose et al., 2002). Synthetic complementary single-stranded oligo-
nucleotide DNAs were annealed to make double-stranded DNAs of the 
target sequences. These annealed DNA were inserted into a pcPUR+U6i 
cassette vector, and the plasmids were electroporated into differentiated 
3T3-L1 adipocytes.
Immunoprecipitation and immunoblotting
Cells were lysed in lysis buffer (20 mM Hepes, pH 7.2, 100 mM NaCl, 
1 mM EDTA, 25 mM NaF, 1 mM sodium vanadate, 1 mM benzamidine, 
5 μg/ml leupeptin, 5 μg/ml aprotinin, 1 mM PMSF, and 1 mM DTT), and 
the protein concentration was measured with bicinchoninic acid protein 
assay reagent (Pierce Chemical Co.). For immunoprecipitation, the cell 
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to remove nonspeciﬁ  c bound protein. Then, samples were incubated with 
primary antibody at 4°C for 2 h followed by incubation with protein G–
Sepharose beads. Lysates and immunoprecipitates were resolved by 
SDS-PAGE and transferred to a polyvinylidene diﬂ   uoride membrane 
(GE Healthcare). The membrane was preblotted in milk buffer for 1 h and 
immunoblotted with primary antibody for 2 h. HRP-conjugated secondary 
antibodies (Jackson ImmunoResearch Laboratories) were used, and proteins 
were visualized using an enhanced chemiluminescence substrate kit 
(GE Healthcare).
2-deoxyglucose uptake
Differentiated adipocytes were prepared in 24-well plates. Cells were 
  infected with the recombinant adenoviruses. 2 d thereafter, the cells were 
serum starved for 2 h at 37°C in Krebs-Ringer phosphate buffer (130 mM 
NaCl, 5 mM KCl, 1.3 mM CaCl2, 1.3 mM MgSO4, and 10 mM Na2HPO4, 
pH 7.4) and were treated with or without 20 ng/ml TNF-α for 4 h. Next, 
the cells were stimulated with or without 100 nM insulin for 5 min, and 
2-deoxyglucose uptake was determined by 2-deoxy-D-[2,6 
3H] glucose 
  incorporation. Nonspeciﬁ   c deoxyglucose uptake was measured in the 
presence of 20 μM cytochalasin B and subtracted from each determination 
to obtain speciﬁ  c uptake. The deoxyglucose uptake was corrected using 
the protein amount.
In vitro kinase assay
3T3-L1 adipocytes were infected with the recombinant adenoviruses as 
  indicated. 2 d after the infection, cells were stimulated with or without 
20 ng/ml TNF-α for 5 min, and cell lysates were prepared. After adjusting 
the protein concentration, immunoprecipitation using anti–IKK-β antibody 
was performed. Precipitates were mixed with IKK substrate peptide 
(K  K  K  K  E  R  L  L  D  D  R  H  D  S  G  L  D  S  M  K  D  E  E  ; Upstate Biotechnology) and γ-[
32P] ATP. 
After a 10-min incubation at 30°C, samples were transferred to P81 
  paper (Whatman) and washed with 0.75% phosphoric acid and acetone. 
Radioactivity was counted using a scintillation counter.
Statistical analysis
Multiple comparisons among groups were performed using the one-  factor 
analysis of variance test (post-hoc test; Turkey-Kramer). Results are presented as 
means ± SD. Values of P < 0.05 were considered statistically signiﬁ  cant.
Online supplemental material
Fig. S1 shows the results of pull-down experiments to demonstrate the   direct 
interaction of NEMO with Myo1c. Fig. S2 shows the effects of NEMO knock-
down on Myo1c–IKK-β interaction (A) and the effects of NEMO   expression 
on IRS-1–IKK-β interaction (B). Fig. S3 shows the effects of Myo1c expres-
sion on the TNF-α–induced phosphorylation of IRS-1 Ser
307 (A) and the 
effects of WT NEMO and ∆N-NEMO expression or NEMO knockdown on 
IKK-β kinase activity (B and C). Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200601065/DC1.
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